All the promised trial details are here:
Boston, US
Brigham and Women's Hospital
Principal Investigator: Tanuja Chitnis, MD
tchitnis@bwh.harvard.edu
Ottawa, Canada
The Ottawa Hospital
Principal Investigator: Gauruv Bose, MD
gabose@toh.ca
London, UK
The Royal London Hospital
Principal Investigator: Sharmilee Gnanapavan, Dr.
s.gnanapavan@qmul.ac.uk
Inclusion criteria:
Participants must have a diagnosis of Multiple Sclerosis (MS) within an age range of 18 to 60.
The participant must have an Extended Disability Status Scale (EDSS) score at screening less than or equal to 6.5, inclusive.
As background, the main study is 6 months in duration, with an option for the participant to continue for an additional 6 months.
For reference, here is a public link where we publish info on the MS study, including site contact info:
https://clinicaltrials.gov/study/NCT05781113?term=NCT05781113&city=&rank=1
Please Subscribe to the channel, ring the bell to be notified of new content, and if you really enjoy it then please support me by becoming a Patreon supporter. Thank you.
https://www.patreon.com/theMSguide
theMSguide.com is nothing without your help. Please get in touch and let me know what you need to know. I'll reach out and do my level best to get the best answers for you.
After 31y of #MS I have accumulated a wide network of contacts, so I am sure we can work together to answer any questions you have about MS. I look forward to hearing from you.
Email: dominic@theMSguide.com
Twitter: @theMSguide
LinkedIn: https://www.linkedin.com/company/themsguide/
Instagram: @theMSguide
Facebook: facebook.com/MultipleSclerosisGuide (I am really bad at Facebook - please email me!)
Hosted on Acast. See acast.com/privacy for more information.
